<i>MUTYH</i> as an Emerging Predictive Biomarker in Ovarian Cancer
Approximately 18% of ovarian cancers have an underlying genetic predisposition and many of the genetic alterations have become intervention and therapy targets. Although mutations in MutY homolog (<i>MUTYH</i>) are best known for <i>MUTYH</i> associated polyposis and colorect...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-01-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/11/1/84 |